{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:03:56Z","timestamp":1781600636742,"version":"3.54.5"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>Abstract:<\/jats:title>\n            <jats:p>A survey of 461 HIV-infected Kenyan children receiving antiretroviral therapy found 143 (31%) failing virologically. Drug resistance mutations were found in 121; 37 had L74V\/I mutations, with 95% receiving abacavir (ABC)-containing regimens. L74V\/I was associated with current ABC usage (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0001). L74V\/I may be more prevalent than previously realized in children failing ABC-containing regimens, even when time on treatment has been short. Ongoing rigorous pediatric drug resistance surveillance is needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001597","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T19:47:57Z","timestamp":1491508077000},"page":"758-760","source":"Crossref","is-referenced-by-count":4,"title":["High Prevalence of Abacavir-associated L74V\/I Mutations in Kenyan Children Failing Antiretroviral Therapy"],"prefix":"10.1097","volume":"36","author":[{"given":"Eric J.","family":"Dziuban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"DeVos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Ngeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Ngugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karidia","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Nganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Katana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia D.","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Odhiambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Redfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Raizes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20231020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QAI.0b013e31827b4ac8","article-title":"Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy.","volume":"62","author":"Wamalwa","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"e97067","DOI":"10.1371\/journal.pone.0097067","article-title":"High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen.","volume":"9","author":"Steegen","year":"2014","journal-title":"PLoS One"},{"key":"R7-20231020","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool.","volume":"50","author":"Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/INF.0b013e31828c3738","article-title":"Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children.","volume":"32","author":"Technau","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/AAC.49.7.2648-2656.2005","article-title":"The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.","volume":"49","author":"Miranda","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201708000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:05:39Z","timestamp":1697774739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201708000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001597","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}